Long Term Debt Summary of Traws Pharma, Inc.

Traws Pharma, Inc.'s latest annual long term debt in 2023 was - USD , down 0.0% from previous year.
Traws Pharma, Inc.'s latest quarterly long term debt in 2024 Q1 was - USD , down 0.0% from previous quarter.
Traws Pharma, Inc. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
Traws Pharma, Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
Traws Pharma, Inc. reported quarterly long term debt of - USD for 2024 Q2, down 0.0% from previous quarter.
Traws Pharma, Inc. reported quarterly long term debt of - USD for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Traws Pharma, Inc. (2023 - 2016)

Name	Long Term Debt	Long Term Debt Difference
Bayview Acquisition Corp Right	- USD	NaN%
Binah Capital Group, Inc. Warrants	42.54 Million USD	100.0%
The Baldwin Insurance Group, Inc.	30.28 Million USD	100.0%
DigiAsia Corp.	- USD	NaN%
DigiAsia Corp.	- USD	NaN%
Global Star Acquisition, Inc. Right	- USD	NaN%
IB Acquisition Corp. Right	- USD	NaN%
Next Technology Holding Inc.	- USD	NaN%
Psyence Biomedical Ltd. Warrant	- USD	NaN%
Quetta Acquisition Corporation Right	- USD	NaN%
SRIVARU Holding Limited Warrant	- USD	NaN%
Trinity Capital Inc. 7.875% Notes due 2029	639.61 Million USD	100.0%
Vast Renewables Limited Warrants	13.12 Million USD	100.0%
Waystar Holding Corp.	2.19 Billion USD	100.0%
Zapata Computing Holdings Inc. Warrant	8.9 Million USD	100.0%